29216 Federal Register / Vol. 74, No. 117 / Friday, June 19, 2009 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of 

respondents Form name Number of respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

State Education Agency Contacts .................. State Recruitment Script ................................ 17 1 30/60 

School District Contacts ................................. District Recruitment Script .............................. 80 1 30/60 

School Administrators ..................................... School Recruitment Script .............................. 133 1 30/60 

Teachers ......................................................... Data Collection Checklist and Make-up Form 400 1 15/60 

Students .......................................................... NYPANS Questionnaire ................................. 8,000 1 45/60 

Height and Weight Record Form ................... 8,000 1 3/60 

Student Contact Form .................................... 1,200 1 2/60 

24–Hour Dietary Recall Interview Script ........ 750 3 30/60 

Dated: June 15, 2009. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–14411 Filed 6–18–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Proposed Projects 

Title: Head Start Eligibility 

Verification. 

OMB No.: New Collection. 

Description: The requirements for 

establishing proof of eligibility for the 

enrollment of children in Head Start 

programs are documented in 45 CFR 

1305.4(e). Each child’s record must 

include a signed document by an 

employee identifying those documents 

which were reviewed to determine 

eligibility. Presently there is no uniform 

document which the employee must 

sign. This form will be used to facilitate 

an efficient and accurate determination 

of childrens’ eligibility for Head Start 

enrollment. 

Respondents: Head Start grantees. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Head Start Eligibility Verification ...................................................................... 1,600 750 0.08 96,000 

Estimated Total Annual Burden 

Hours: 96,000. 

In compliance with the requirements 

of Section 506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. E-mail address: 

infocollection@acf.hhs.gov. All requests 

should be identified by the title of the 

information collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Dated: June 16, 2009. 

Janean Chambers, 

Reports Clearance Officer. 

[FR Doc. E9–14482 Filed 6–18–09; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0262] 

Clinical Trials Transformation Initiative 

(U19) 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

availability of grant funds to support the 

Clinical Trials Transformation Initiative 

(CTTI). The goal of CTTI is to support 

modernization of the clinical trial 

enterprise by identifying practices that 

will enhance human subject protection, 

boost the quality of information derived 

from clinical trials, and make the 

research process more efficient. 

DATES: Important dates are as follows: 

1. The application is due by: July 6, 

2009. 

2. The anticipated start date is in: 

September 2009. 

mstockstill on PROD1PC66 with NOTICES

Federal Register / Vol. 74, No. 117 / Friday, June 19, 2009 / Notices 29217 

FOR FURTHER INFORMATION CONTACT: 

Programmatic/Review Contact: 

Melissa Robb, Office of the 

Commissioner, Food and Drug 

Administration, 5600 Fishers Lane, 

rm. 14B–45, Rockville, MD 20857, 

301–827–1516, 

Melissa.robb@fda.hhs.gov 

Grants Management Contact: Gladys 

M. Bohler, OAGS, Food and Drug 

Administration, 5630 Fishers Lane, 

rm. 2105, Rockville, MD 20857, 

301–827–7168, 

gmbohler@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Funding Opportunity Description 

Funding Opportunity Number: RFA– 

FD–09–011 

Catalog of Federal Domestic 

Assistance Number: 93.103 

A. Background 

The Critical Path Initiative, launched 

by FDA in 2004, has the objective of 

helping modernize the development, 

evaluation, manufacture, and use of 

FDA-regulated products. Through 

nationwide collaboration with other 

Federal, academic, scientific, and 

industry organizations, the initiative 

seeks to develop new tools to facilitate 

innovation in FDA-regulated product 

development. Examples of tools include 

novel biomarkers, laboratory assays, 

genetic tests, and state-of-the art 

information technologies, etc. In this 

initiative, FDA plays the role of a 

facilitator in the creation of partnerships 

and collaborations to support specific 

scientific projects. 

FDA and Duke University’s 

Department of Translational Medicine 

Institute (DTMI) co-founded CTTI. 

CTTI’s goal is to systematically 

modernize the clinical trial process, a 

goal shared by FDA’s Critical Path 

Initiative. CTTI is made up of a broad 

representation of member organizations 

including government, industry, patient 

advocacy groups, professional societies, 

and academia. The participants are 

working together to identify practices 

that through broad adoption will 

increase the quality and efficiency of 

clinical trials. 

CTTI is generating evidence about 

how to improve the design and 

execution of clinical trials. Projects 

about design will address principles 

generally applicable to clinical trials to 

ensure that they are fit to accomplish 

their intended purpose. 

B. Research Objectives 

The goals of this program are to 

develop an administrative and scientific 

infrastructure to support the creation 

and execution of a series of projects 

under the auspices of CTTI, to 

complement the goals of FDA’s Critical 

Path Initiative. 

This funding opportunity will use a 

cooperative agreement award 

mechanism (U19). In the cooperative 

agreement mechanism, the Project 

Director/Principal Investigator (PD/PI) 

retains the primary responsibility and 

dominant role for planning, directing, 

and executing the proposed project, 

with FDA staff being substantially 

involved as a partner with the PD/PI. 

Substantive involvement includes, but 

is not limited to, the following: (1) FDA 

will work closely with the DTMI 

throughout the lifetime of this program 

and throughout all phases of planning, 

implementation, conduct and reporting 

of this program and all related projects; 

(2) FDA will appoint project officer (s) 

for the task(s) associated with this 

program and related projects; (3) FDA 

will identify appropriate staff to provide 

strategic and scientific input, as needed, 

throughout the life of this program and 

related projects. 

C. Eligibility Information 

This is a sole source award to DTMI 

located within Duke University to 

support the CTTI. Only one award will 

be made to the DTMI to support the 

CTTI. 

II. Award Information/Funds Available 

A. Award Amount 

FDA anticipates providing up to $1.5 

million (direct and indirect costs 

combined) during fiscal year 2009 to 

support research and related efforts of 

identified projects that are part of the 

Critical Path Initiative. 

B. Length of Support 

Subject to the availability of Federal 

funds and successful performance of the 

funding opportunity announcement 

(FOA) stated goals and objectives, 4 

additional years of support may be 

available depending on annual 

appropriations. This award will be 

funded based on the quality of the 

application received and is subject to 

availability of Federal funds to support 

the program. 

III. How to Submit a Paper Application 

To submit a paper application in 

response to this FOA, applicants should 

first review the full announcement 

located at http://www.fda.gov/ 

ScienceResearch/SpecialTopics/ 

CriticalPathInitiative/ 

SpotlightonCPIProjects/ 

ucm083241.htm. Persons interested in 

applying for a grant may obtain 

application forms and instructions at 

http://grants.nih.gov/grants/forms.htm. 

For paper submissions, the following 

steps are required: 

• Step 1: Obtain a Dun and Bradstreet 

Data Universal Numbering System 

(DUNS) Number 

• Step 2: Register with Central 

Contractor Registration (CCR) 

Instructions on how to complete these 

steps can be found at http:// 

www07.grants.gov/applicants/ 

organization_registration.jsp 

Submit paper applications to: Gladys 

M. Bohler, OAGS/GAAT, Food and 

Drug Administration, 5630 Fishers Lane 

(HFA–500), rm. 2105, Rockville, MD 

20874. 

Dated: June 15, 2009. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E9–14436 Filed 6–18–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Office of Child Support Enforcement 

AGENCY: Office of Child Support 

Enforcement (OCSE), Administration for 

Children and Families (ACF), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice to administratively 

impose a matching requirement. 

CFDA Number: 93.564. 

Legislative Authority 

Section 1115 of the Social Security 

Act [42 U.S.C. 1315] provides funds for 

experimental, pilot or demonstration 

projects that are likely to assist in 

promoting the objectives of Part D of the 

Title IV. The projects must be designed 

to improve the financial well-being of 

children or otherwise improve the 

operation of the child support program. 

Projects may not permit modifications 

in the child support program that would 

have the effect of disadvantaging 

children in need of support. 

SUMMARY: The Office of Child Support 

Enforcement (OCSE) in the 

Administration for Children and 

Families (ACF) hereby gives notice to 

the public that a matching requirement 

of five percent (5%) will be 

administratively imposed upon awards 

made under competitions governed by 

the following ‘‘Section 1115’’ funding 

opportunities in Fiscal Year 2009. 

mstockstill on PROD1PC66 with NOTICES